AI Article Synopsis
- Dyslipidemia is highly prevalent in Bangladeshi adults, with an overall rate of 89%, affecting both genders similarly; main issues include low HDL levels and high triglycerides.
- The study analyzed 603 adults, measuring various lipid levels and identifying specific types of dyslipidemia such as hypertriglyceridemia and hypercholesterolemia.
- Significant risk factors for dyslipidemia included older age, being overweight, obesity, hypertension, diabetes, and lack of physical activity.
Article Abstract
Background: Dyslipidemia is one of the modifiable risk factors for cardiovascular disease and a leading cause of morbidity and mortality worldwide. This study was designed to estimate the prevalence and factors associated with dyslipidemia in Bangladeshi adults.
Methods: A total of 603 participants aged ≥ 18 years were recruited in the study. Serum levels of total cholesterol (TC), triglycerides (TG), low-density lipoprotein (LDL) and high-density lipoprotein (HDL) were analyzed using enzymatic colorimetric methods. Dyslipidemia was defined based on serum lipids levels following the standard guidelines by National Cholesterol Education Program Adult Treatment Panel III. Multivariate logistic regression analysis was applied to evaluate risk factors associated with dyslipidemia.
Results: The overall prevalence of dyslipidemia was 89% with no significant difference between male (90.1%) and female (85.7) subjects. The prevalence of hypertriglyceridemia was 51.7%, hypercholesterolemia 41.6%, high LDL 43.9% and low HDL 78.8%. When participants were classified into healthy control, hypertensive and diabetic groups, the lipid levels and prevalence of lipid abnormalities were higher in hypertensive and diabetic groups compared to the control group. Low HDL level was the main prevalent dyslipidemia among study subjects. The prevalence of isolated hypertriglyceridemia, isolated hypercholesterolemia, and isolated low HDL-C was 24.7%, 14.7%, and 25.5%, respectively. Mixed hyperlipidemia was prevalent in 26.9% of the participants. According to the logistic regression analysis, significant associated factors of dyslipidemia were increased age, overweight, general and abdominal obesity, hypertension, diabetes and inadequate physical activity.
Conclusions: This study shows a high prevalence of dyslipidemia in Bangladeshi adults. Important risk factors of dyslipidemia are increased age, overweight, general and abdominal obesity, diabetes, hypertension and low physical activity. Our results suggest that awareness-raising programs are required to prevent and control dyslipidemia among Bangladeshi adults.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857990 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0280672 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Rheumatoid-like hand deformities and aortic valve disease in a 13-year-old girl with homozygous familial hypercholesterolemia: a case report.
J Med Case Rep
February 2025
Tropical Disease and Health Research Center, Dhaka, 1100, Bangladesh.
Background: Familial hypercholesterolemia is an autosomal dominant disorder characterized by elevated serum low-density lipoprotein cholesterol levels, tendon xanthomas, and an increased risk of atherosclerotic heart disease. Diagnosing familial hypercholesterolemia at an early age is crucial owing to its potential to lead to severe cardiovascular complications, including coronary heart disease and aortic valve disease. Early detection allows timely intervention, such as lifestyle modifications and pharmacological treatments, which can significantly reduce these risks.
View Article and Find Full Text PDFStatus of lipid control in Bangladeshi subjects with type 2 diabetes mellitus on lipid-lowering drugs: a multicenter, facility-based, cross-sectional study.
BMC Endocr Disord
December 2023
Department of Endocrinology, Mymensingh Medical College, Mymensingh, Bangladesh.
Background: Achievement of lipid targets is crucial in patients with type 2 diabetes mellitus (T2DM) to mitigate the risk of cardiovascular diseases (CVD). Data on lipid-control status among patients with T2DM in Bangladesh are scarce. This study was conducted to determine the lipid-control status among patients with T2DM who were on lipid-lowering drugs in the country.
View Article and Find Full Text PDFPrevalence, pattern, and correlates of dyslipidemia in Bangladeshi individuals.
J Clin Lipidol
December 2023
International Centre for Diarrhoeal Disease Research (Drs Samad Talha, Shafiq, Siraj), Bangladesh.
Article Synopsis
- Dyslipidemia, or abnormal lipid levels, is highly prevalent in Bangladesh, affecting 76.7% of adults, with notable variations across regions, particularly higher in Sylhet.
- The study analyzed a sample of 7,084 adults, identifying high triglycerides (35.7%), low HDL cholesterol (63.8%), and significant predictors of dyslipidemia including male sex, age, and tobacco use.
- Urgent lifestyle interventions are needed to address the high rates of dyslipidemia, as current control rates for LDL and non-HDL cholesterol remain very low among those with cardiovascular disease history.
Prevalence and factors associated with dyslipidemia in Bangladeshi adults.
PLoS One
January 2023
Department of Biochemistry and Molecular Biology, Shahjalal University of Science and Technology, Sylhet, Bangladesh.
Article Synopsis
- Dyslipidemia is highly prevalent in Bangladeshi adults, with an overall rate of 89%, affecting both genders similarly; main issues include low HDL levels and high triglycerides.
- The study analyzed 603 adults, measuring various lipid levels and identifying specific types of dyslipidemia such as hypertriglyceridemia and hypercholesterolemia.
- Significant risk factors for dyslipidemia included older age, being overweight, obesity, hypertension, diabetes, and lack of physical activity.
Generalizability of the REDUCE-IT trial to South Asians with cardiovascular disease.
Med
February 2023
Division of Cardiac Surgery, St. Michael's Hospital of Unity Health Toronto, 30 Bond Street, Toronto, ON M5B 1W8, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada; North York Diagnostic and Cardiac Centre, Toronto, ON, Canada; Department of Surgery, University of Toronto, Toronto, ON, Canada. Electronic address:
Article Synopsis
- The study looked at 200 South Asian participants in Canada with existing cardiovascular disease to see how well the results of a previous study (REDUCE-IT) on a medication called icosapent ethyl (IPE) could apply to them.
- Findings showed that many of these high-risk, statin-treated South Asians are eligible for IPE, highlighting a significant need for tailored treatments within this demographic to help reduce their higher cardiovascular risks.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!